
Company: Johnson & Johnson Services, Inc.
Location: Hyderabad, Telangana, India
Johnson & Johnson is a global leader in healthcare innovation, delivering breakthroughs in medicine and medical technology. Our mission is to prevent, treat, and cure complex diseases through smarter, less invasive, and more personalized solutions.
We are looking for exceptional graduate-level interns to join our R&D IT team. This program is tailored for candidates from top academic institutions who have proven expertise in AI model development. Interns will work on impactful projects with opportunities for publication or integration into core product lines.
Submit your resume, cover letter detailing academic achievements and AI projects, and links to your GitHub or research portfolio.
Equal Opportunity: Johnson & Johnson is committed to diversity and inclusion, welcoming applicants regardless of race, gender, age, or disability status.

Johnson & Johnson is a globally renowned healthcare conglomerate headquartered in New Brunswick, New Jersey, USA. Founded in 1886, the company is dedicated to improving health and well-being through the development, manufacturing, and marketing of pharmaceuticals, medical devices, and consumer health products. Its mission is to blend heart, science, and ingenuity to profoundly change the trajectory of health for humanity. Johnson & Johnson employs over 150,000 people worldwide, making it one of the largest and most influential healthcare companies in the world.
J&J is widely recognized for iconic consumer brands such as Tylenol, Band-Aid, and Neutrogena, as well as for its significant pharmaceutical and medical device divisions. The company consistently ranks among the world's most admired corporations for its commitment to innovation, quality, and corporate responsibility. In recent years, Johnson & Johnson has been at the forefront of global health initiatives, notably developing a COVID-19 vaccine and advancing research in oncology, immunology, and digital surgery. In 2023, the company completed the spin-off of its consumer health division into a new publicly traded company, Kenvue, marking a significant strategic shift to focus on pharmaceuticals and medical devices.
Websitejnj.com